HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis.

Abstract
In era of systemic chemotherapy for colorectal liver metastasis (CLM), role of hepatic intraarterial infusion chemotherapy (HAIC) remains important. We examined treatment effects of HAIC in 36 patients with non-resectable CLM using 5-FU or CPT-11. Tumor response was complete response (CR) in 4, partial response (PR) in 19, stable disease (SD) in 6, and progressive disease (PD) in 7. Tumor control rate was 81% and response rate was 64%. Six patients showed catheter-related complications. Median survival period was 62 months in CR, and 25 with PR. HAIC has a major impact in high chemotherapy response and prolonging survival.
AuthorsAtsushi Nanashima, Hiroaki Takeshita, Takafumi Abo, Kazuo Tou, Kenji Tanaka, Daisuke Fukuda, Masaki Kunizaki, Shigekazu Hidaka, Terumitsu Sawai
JournalJournal of gastrointestinal oncology (J Gastrointest Oncol) Vol. 4 Issue 2 Pg. 164-72 (Jun 2013) ISSN: 2078-6891 [Print] China
PMID23730512 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: